Filing Flows › Option Care Health (OPCH) › Guidance & outlook
Option Care Health (OPCH) guidance and outlook
Option Care Health's 10-Q filed Nov 4, 2026 makes 3 forward-looking statements, 1 of them new and 1 no longer said since the filing before.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 4, 2026
- new · Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company (the “Merger”), with the Company continuing as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent.
- Management continues to expect CID-related dynamics to negatively impact gross profit by approximately $55 million during 2026.
- Ongoing investing cash flows are primarily associated with capital projects and business acquisitions, the improvement and maintenance of our pharmacy facilities and investment in our information technology systems.
Option Care Health's latest quarter
Option Care Health, Q3 2026: revenue $1.5B (+4% year over year), operating margin 6.0%, net earnings $57.4M, operating cash flow $115M. The chart follows the revenue to costs, profit and cash.
Questions
What does Option Care Health expect?
Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company (the “Merger”), with the Company continuing as the surviving corporation of the Merger and as a wholly owned subsidiary of Parent.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.